Most peripheral neuropathy treatments focus on managing symptoms, primarily through medications like Gabapentin and Lyrica that reduce pain perception without addressing the underlying nerve damage. Our approach is different. Using shockwave therapy and other treatment modalities, we target the mechanisms behind nerve damage directly: poor microcirculation, inflammation, and dormant nerve fibers. Results are tracked with FLIR thermal imaging throughout treatment, so improvement isn't just felt, it's measurable.

Diabetic neuropathy develops when chronically high blood sugar damages the small blood vessels that supply peripheral nerves. Without adequate circulation, nerves deteriorate, producing the burning, numbness, and tingling that characterize the condition. Our approach addresses both the vascular and neurological components of this damage, restoring microcirculation and stimulating nerve fiber regeneration.

Standard physical therapy addresses strength, mobility, and compensation. Valuable goals, but not the same as treating the nerve tissue itself. Most PT approaches don't include shockwave therapy or the other modalities in our treatment. Our approach targets the nerve fibers and vascular supply driving your symptoms, not just how you move around them.

Chemotherapy-induced peripheral neuropathy occurs when neurotoxic agents damage the peripheral nerves, leaving cancer survivors with persistent burning, numbness, and tingling in the hands and feet long after treatment ends. Our approach is gentle and non-invasive. Shockwave therapy and our other treatment modalities promote cellular repair and reduce inflammation in order to support your body.

Gabapentin and Lyrica only reduce the perception of nerve pain. Our approach is entirely non-pharmaceutical: no medications, no injections, no surgery. The goal isn't indefinite symptom management: it's restored nerve function.